K. Takeyama (Tokyo , Japan), M. Breyer (Vienna, Austria), P. Camus (Dijon, France), S. Skoczynski (Katowice, Poland)
Pulmonary embolism in COPD patients
E. Shehu, J. Bushati (Tirana, Albania)
|  |
Effects of ciclesonide on the management of stable COPD with airway eosinophilia
H. Kume, O. Nishiyama, Y. Higashimoto, H. Nakajima, Y. Tohda (Osakasayama, Japan)
|  |
The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation
S. Atis Nayci, E. Özgür, C. Özge, Y. Duman, E. Tastekin, A. Ilvan (Mersin, Turkey)
| |
Clinical effectiveness of antidepressive drug in patients with COPD and concomitant moderate depressive episode
Y. Feshchenko, L. Iashyna, M. Polianska, I. Zvol, A. Potocjniak, L. Savelieva (Kiev, Ukraine)
| |
Comparative study of hospitalized patients with acute exacerbation of COPD with and without carbon dioxide retention
V. Sharma, A. Bhat, D. S. Harsha, V. Viswambhar (Mangalore, Chennai, India)
| |
Recruitment for psychological therapy in chronic obstructive pulmonary disease (COPD) What factors influence participation?
K. Heslop, C. Stenton, M. Jambon, J. Newton, D. Carrick-Sen, C. Baker, G. Burns, A. De Soyza (Newcastle, United Kingdom)
| |
Does the 2011 GOLD staging of COPD reflect phenotype and severity of the disease as assessed by CT?
F. Bigazzi, M. Paoletti, E. Torricelli, V. Luzzi, A. Garcea, M. Vannini, L. Corsi, V. Bellino, L. Cestelli, G. Camiciottoli, M. Pistolesi (Florence, Italy)
| |
Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD
K. Gashynova (Dnipropetrovsk, Ukraine)
| |
Detection of chronic obstructive pulmonary disease (COPD) in patients with cardio-vascular system pathology
D. Mihailichenko, T. Pertseva (Dnipropetrovsk, Ukraine)
| |
Adipokines and ghrelin in chronic obstructive pulmonary disease
E. Kochetkova, L. Ugay, Y. Maistrovskaya, T. Sourovenko, G. Massard (Vladivostok, Russian Federation; Strasbourg, France)
| |
Mediation of the effect of airflow obstruction upon six minute Walking distance (6MWD) by cytokine IL6 plasma levels in chronic obstructive pulmonary disease (COPD)
S. Baldi, C. Bruschi, A. Rezzani, E. Bellinzona, E. Dacosto, P. Crotti, C. Fracchia (Montescano, Italy)
| |
The most frequent comorbidies in COPD and their inflence on the prognosis of the disease
J. Stojkovic, D. Stojkovic (Skopje, Fyrom)
| |
A survey of the perception of COPD by primary care physicians in Republic of Moldova
A. Corlateanu, E. Cornei, V. Botnaru, O. Corlateanu (Chisinau, Republic Of Moldova)
| |
Effects of sitting time on dyspnea, quality of life, and BODE score in chronic obstructive pulmonary disease
S. Savci, D. Inal-Ince, M. Saglam, N. Vardar-Yagli, E. Calik, H. Arikan, L. Coplu, M. Bosnak-Guclu (Izmir, Ankara, Turkey)
| |
COPD; IPF; lung cancer in same individual: Can it be called 'AJMERITES SYNDROME?
N. Gupta, N. Singh, S. Jangir, V. Mishra, R. Kuldeep (Ajmer, India)
| |
Prevalence and goals in the managing of COPD patients in COPD-school
L. Botvinikova, B. Basina, A. Garagulya (Dnepropetrovsk, Ukraine)
| |
Principles of optimization of anti-inflammatory therapy in COPD patients (pts) due to C-reactive protein (CRP) level
B. Basina, T. Pertseva, L. Konopkina (Dnipropetrovsk, Ukraine)
| |
Carotid wall intima-media thickness (IMT) in COPD patients
Z. Arsovski, M. Gavrilovski, B. Kaeva, K. Busljetic, A. Arsovska (Skopje, Fyrom)
| |
Psychological status in COPD patients of Kirov region
V. Pyankov, Y. Chuyasova (Kirov, Russian Federation)
| |